219 related articles for article (PubMed ID: 15225014)
1. Incidence of anticoagulation in patients with bioprostheses.
Gherli T; Colli A; Nicolini F
J Heart Valve Dis; 2004 May; 13 Suppl 1():S88-9. PubMed ID: 15225014
[No Abstract] [Full Text] [Related]
2. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database.
Brennan JM; Edwards FH; Zhao Y; O'Brien S; Booth ME; Dokholyan RS; Douglas PS; Peterson ED;
J Am Coll Cardiol; 2012 Sep; 60(11):971-7. PubMed ID: 22921973
[TBL] [Abstract][Full Text] [Related]
3. Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation.
Nuñez L; Pinto AG; Larrea JL; Gil Aguado M; Connor FO
Z Kardiol; 1986; 75 Suppl 2():321-5. PubMed ID: 3727711
[No Abstract] [Full Text] [Related]
4. Oral anticoagulation in patients with mechanical valve prostheses: evolving protocols with new generation devices.
Cotrufo M; De Feo M; De Santo LS; Della Corte A; Scardone M; Costanza S
Ital Heart J; 2005 May; 6(5):401-4. PubMed ID: 15934413
[No Abstract] [Full Text] [Related]
5. Anticoagulation or antiplatelet therapy of bioprosthetic heart valves recipients: an unresolved issue.
Colli A; Verhoye JP; Leguerrier A; Gherli T
Eur J Cardiothorac Surg; 2007 Apr; 31(4):573-7. PubMed ID: 17317197
[TBL] [Abstract][Full Text] [Related]
6. Testing a no-warfarin heart valve.
Harv Heart Lett; 2006 Apr; 16(8):7. PubMed ID: 19685564
[No Abstract] [Full Text] [Related]
7. Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis.
Brott WH; Zajtchuk R; Bowen TE; Davia J; Green DC
J Thorac Cardiovasc Surg; 1981 Apr; 81(4):632-5. PubMed ID: 7206773
[TBL] [Abstract][Full Text] [Related]
8. Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?
Sundt TM; Zehr KJ; Dearani JA; Daly RC; Mullany CJ; McGregor CG; Puga FJ; Orszulak TA; Schaff HV
J Thorac Cardiovasc Surg; 2005 May; 129(5):1024-31. PubMed ID: 15867776
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulation in valvular heart disease preoperatively and postoperatively.
Bodnar AG; Hutter AM
Cardiovasc Clin; 1984; 14(3):247-64. PubMed ID: 6722854
[TBL] [Abstract][Full Text] [Related]
10. eComment: Freedom from complications related to dual ball-and-cage mechanical valve prostheses despite thirty years without anticoagulation.
Bockeria LA; Skopin II; Kuts EV
Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1169. PubMed ID: 19029395
[No Abstract] [Full Text] [Related]
11. Comparing warfarin to aspirin (WoA) after aortic valve replacement with the St. Jude Medical Epic heart valve bioprosthesis: results of the WoA Epic pilot trial.
Colli A; Mestres CA; Castella M; Gherli T
J Heart Valve Dis; 2007 Nov; 16(6):667-71. PubMed ID: 18095518
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors.
Brueck M; Kramer W; Vogt P; Steinert N; Roth P; Görlach G; Schönburg M; Heidt MC
Eur J Cardiothorac Surg; 2007 Jul; 32(1):108-12. PubMed ID: 17449264
[TBL] [Abstract][Full Text] [Related]
13. The experience with porcine bioprostheses at Padua University.
Gerosa G; Rizzoli G; Di Marco F; Bottio T; Thiene G; Casarotto D
J Heart Valve Dis; 2004 May; 13 Suppl 1():S44-8. PubMed ID: 15225001
[No Abstract] [Full Text] [Related]
14. Discrepancy in guidelines for the prevention of thrombo-embolism in patients with prosthetic heart valves.
Stefanidis A; Skafidas D; Papasteriadis E
Eur Heart J; 2007 Oct; 28(20):2552-3; author reply 2553-4. PubMed ID: 17823214
[No Abstract] [Full Text] [Related]
15. Prevention of thromboembolic events after bioprosthetic aortic valve replacement: what is the optimal antithrombotic strategy?
Whitlock RP; Eikelboom JW
J Am Coll Cardiol; 2012 Sep; 60(11):978-80. PubMed ID: 22921974
[No Abstract] [Full Text] [Related]
16. Safety and Use of Anticoagulation After Aortic Valve Replacement With Bioprostheses: A Meta-Analysis.
Riaz H; Alansari SA; Khan MS; Riaz T; Raza S; Luni FK; Khan AR; Riaz IB; Krasuski RA
Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):294-302. PubMed ID: 27166205
[TBL] [Abstract][Full Text] [Related]
17. [A study on prosthetic valves with reference to anticoagulation-related complications].
Sakashita I; Otani S; Hayashi J; Eguchi S
Rinsho Kyobu Geka; 1981; 1(1):43-55. PubMed ID: 7052581
[No Abstract] [Full Text] [Related]
18. Freedom from complications related to dual ball-and-cage mechanical valve prostheses despite thirty years without anticoagulation.
Miller MM; Hipp R; Matsumura ME
Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1167-9. PubMed ID: 18669529
[TBL] [Abstract][Full Text] [Related]
19. [Thrombocytosis of mechanical prosthetic heart valves is al life-threatening condition. Thrombocyte inhibition possible as treatment and prevention].
Stenudd J; Linder R
Lakartidningen; 2011 May 4-10; 108(18):988-91. PubMed ID: 21809526
[No Abstract] [Full Text] [Related]
20. [Anticoagulation after heart valve bioprosthesis].
Hamm CW
Dtsch Med Wochenschr; 1991 Mar; 116(13):514. PubMed ID: 2007385
[No Abstract] [Full Text] [Related]
[Next] [New Search]
